No Data
Why Viking Therapeutics Stock Was Victorious This Week
Viking Therapeutics Call Volume Above Normal and Directionally Bullish
Where Will Viking Therapeutics Be in 3 Years?
Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?
Viking Therapeutics Options Spot-On: On April 29th, 53,329 Contracts Were Traded, With 176.65K Open Interest
Viking Among Notable Gainers as Pfizer Raises Deal Prospects